N. Girerd, M. F. Seronde, S. Coiro, T. Chouihed, P. Bilbault et al.,

P. , R. G. Fillieux, L. Abraham, W. T. Januzzi, J. et al., Integrative Assessment of Congestion in Heart Failure Throughout the Patient Journey, JACC Heart Fail, vol.6, pp.273-285, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01847385

S. D. Pokorney, S. M. Al-khatib, J. L. Sun, P. Schulte, O. Connor et al.,

J. A. Ezekowitz, R. C. Starling, A. A. Voors, E. J. Velazquez, A. F. Hernandez et al., Sudden cardiac death after acute heart failure hospital admission: insights from ASCEND-HF, Eur J Heart Fail, vol.20, pp.525-532, 2018.

M. Gheorghiade, F. Follath, P. Ponikowski, J. H. Barsuk, J. E. Blair et al., European Society of C and European Society of Intensive Care M. Assessing and grading congestion in acute heart failure: a scientific statement from the acute heart failure committee of the heart failure association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine, Eur J Heart Fail, vol.12, pp.423-456, 2010.

W. T. Abraham, P. B. Adamson, R. C. Bourge, M. F. Aaron, M. R. Costanzo et al.,

S. Neelagaru, N. Raval, S. Krueger, S. Weiner, D. Shavelle et al., Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial, Lancet, vol.377, pp.658-66, 2011.

A. P. Ambrosy, P. S. Pang, S. Khan, M. A. Konstam, G. C. Fonarow et al.,

K. Swedberg, J. C. Burnett, J. Grinfeld, L. Udelson, J. E. Zannad et al., Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial, Eur Heart J, vol.34, pp.835-878, 2013.

S. Coiro, N. Girerd, P. Rossignol, J. P. Ferreira, A. Maggioni et al.,

F. Zannad, Association of beta-blocker treatment with mortality following myocardial infarction in patients with chronic obstructive pulmonary disease and heart failure or left ventricular dysfunction: a propensity matchedcohort analysis from the High-Risk Myocardial Infarction Database Initiative, Eur J Heart Fail, 2016.

G. S. Francis, C. Benedict, D. E. Johnstone, P. C. Kirlin, J. Nicklas et al.,

S. Yusuf, Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD)

, Circulation, vol.82, pp.1724-1733, 1990.

W. L. Miller, Fluid Volume Overload and Congestion in Heart Failure: Time to Reconsider Pathophysiology and How Volume Is Assessed, Circ Heart Fail, vol.9, p.2922, 2016.

E. Kaplan, R. C. Puestow, L. A. Baker, and S. Kruger, Blood volume in congestive heart failure as determined with iodinated human serum albumin, Am Heart J, vol.47, pp.824-862, 1954.

K. Duarte, J. M. Monnez, E. Albuisson, B. Pitt, F. Zannad et al., Prognostic Value of Estimated Plasma Volume in Heart Failure, JACC Heart Fail, vol.3, pp.886-93, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01236515

H. Z. Ling, J. Flint, M. Damgaard, P. K. Bonfils, A. S. Cheng et al.,

M. Rashid, S. Kang, F. Papalia, S. Weissert, C. J. Coats et al., Calculated plasma volume status and prognosis in chronic heart failure, Eur J Heart Fail, vol.17, pp.35-43, 2015.

M. Kobayashi, P. Rossignol, J. P. Ferreira, I. Aragao, Y. Paku et al.,

K. , Z. F. Girerd, and N. , Prognostic value of estimated plasma volume in acute heart failure in three cohort studies, Clin Res Cardiol, 2018.

T. Chouihed, P. Rossignol, A. Bassand, K. Duarte, M. Kobayashi et al.,

L. , G. G. Hutter, T. Barbe, F. Salignac, S. Jay et al., Diagnostic and prognostic value of plasma volume status at emergency department admission in dyspneic patients: results from the PARADISE cohort, Clin Res Cardiol, 2018.
URL : https://hal.archives-ouvertes.fr/hal-02138898

A. Yoshihisa, S. Abe, Y. Sato, S. Watanabe, T. Yokokawa et al.,

M. , K. A. Yamaki, T. Kunii, H. , S. Si et al., Plasma volume status predicts prognosis in patients with acute heart failure syndromes, Eur Heart J Acute Cardiovasc Care, p.2048872617690889, 2017.

J. R. Balderston, K. B. Shah, P. Sc, and Z. M. Gertz, Usefulness of Estimated Plasma Volume at

, Postdischarge Follow-Up to Predict Recurrent Events in Patients With Heart Failure, Am J Cardiol, vol.122, pp.1191-1194, 2018.

M. Kobayashi, M. Bercker, O. Huttin, S. Pierre, N. Sadoul et al.,

P. Rossignol and N. Girerd, Chest X-ray quantification of admission lung congestion as a prognostic factor in patients admitted for worsening heart failure from the ICALOR cohort study, Int J Cardiol, 2019.
URL : https://hal.archives-ouvertes.fr/hal-02557291

W. L. Miller and B. P. Mullan, Volume Overload Profiles in Patients With Preserved and Reduced Ejection Fraction Chronic Heart Failure: Are There Differences? A Pilot Study, JACC Heart Fail, vol.4, pp.453-462, 2016.

M. Takei, S. Kohsaka, Y. Shiraishi, A. Goda, Y. Izumi et al.,

T. Kohno, K. Fukuda, T. Yoshikawa, and W. Tokyo, Heart Failure Registry I. Effect of estimated plasma volume reduction on renal function for acute heart failure differs between patients with preserved and reduced ejection fraction, Circulation Heart failure, vol.8, pp.527-559, 2015.

C. Y. Huang, T. T. Lin, Y. F. Wu, F. T. Chiang, and C. K. Wu, Long-term Prognostic Value of Estimated Plasma Volume in Heart Failure with Preserved Ejection Fraction, Sci Rep, vol.9, p.14369, 2019.

J. L. Grodin, S. Philips, W. Mullens, P. Nijst, P. Martens et al.,

A. , Prognostic implications of plasma volume status estimates in heart failure with preserved ejection fraction: insights from TOPCAT, Eur J Heart Fail, 2019.

M. Kobayashi, O. Huttin, D. E. Duarte, K. Hubert, A. et al.,

F. Schnell, C. Leclercq, P. Rossignol, and N. Girerd, Association of estimated plasma volume status with hemodynamic and echocardiographic parameters, Clin Res Cardiol, 2020.
URL : https://hal.archives-ouvertes.fr/hal-02470874

D. O. Okonko, F. Jouhra, H. Abu-own, G. Filippatos, J. C. Colet et al., Effect of ferric carboxymaltose on calculated plasma volume status and clinical congestion: a FAIR-HF substudy, ESC Heart Fail, vol.6, pp.621-628, 2019.

B. Pitt, M. A. Pfeffer, S. F. Assmann, R. Boineau, I. S. Anand et al.,

G. I. Jl, B. Harty, J. F. Heitner, C. T. Kenwood, E. F. Lewis et al., Spironolactone for heart failure with preserved ejection fraction, N Engl J Med, vol.370, pp.1383-92, 2014.

M. A. Pfeffer, B. Claggett, S. F. Assmann, R. Boineau, I. S. Anand et al.,

I. Gordeev, J. F. Heitner, E. F. Lewis, E. O'meara, J. L. Rouleau et al., Regional variation in patients and outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) trial, Circulation, vol.131, pp.34-42, 2015.

M. B. Strauss, R. K. Davis, J. D. Rosenbaum, and E. C. Rossmeisl, Water diuresis produced during recumbency by the intravenous infusion of isotonic saline solution, J Clin Invest, vol.30, pp.862-870, 1951.

R. H. Plasmapheresis, Handbook of dialysis, p.236, 2001.

A. S. Levey, J. P. Bosch, J. B. Lewis, T. Greene, R. N. Roth et al., A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group, Ann Intern Med, vol.130, pp.461-70, 1999.

. Fine and R. J. Gray, A proportional hazards model for the subdistribution of a competing risk, J Am Stat Assoc, vol.94, pp.496-509, 1999.

H. Uno, L. Tian, T. Cai, K. Is, and L. J. Wei, A unified inference procedure for a class of measures to assess improvement in risk prediction systems with survival data, Stat Med, vol.32, pp.2430-2472, 2013.

A. P. Ambrosy, L. P. Cerbin, P. W. Armstrong, J. Butler, A. Coles et al.,

G. M. Felker, M. Fudim, S. J. Greene, A. F. Hernandez, O. Connor et al., Body Weight Change During and After Hospitalization for Acute Heart Failure: Patient Characteristics, Markers of Congestion, and Outcomes: Findings From the ASCEND-HF Trial, JACC Heart Fail, vol.5, pp.1-13, 2017.

S. D. Anker, A. Negassa, A. Coats, R. Afzal, P. A. Poole-wilson et al., Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-convertingenzyme inhibitors: an observational study, The Lancet, vol.361, pp.1077-1083, 2003.

D. Abramov, R. S. Cohen, S. D. Katz, D. Mancini, and M. S. Maurer, Comparison of blood volume characteristics in anemic patients with low versus preserved left ventricular ejection fractions, Am J Cardiol, vol.102, pp.1069-72, 2008.

S. Schwartzenberg, M. M. Redfield, A. M. From, P. Sorajja, R. A. Nishimura et al., Effects of vasodilation in heart failure with preserved or reduced ejection fraction implications of distinct pathophysiologies on response to therapy, J Am Coll Cardiol, vol.59, pp.442-51, 2012.

J. M. Testani, J. Chen, B. D. Mccauley, S. E. Kimmel, and R. P. Shannon, Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival, Circulation, vol.122, pp.265-72, 2010.

S. J. Greene, M. Gheorghiade, M. Vaduganathan, A. P. Ambrosy, R. J. Mentz et al.,

S. Nodari, M. A. Konstam, J. Butler, F. G. , I. Et-;-van-der-meer et al., Haemoconcentration, renal function, and post-discharge outcomes among patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial, Eur J Heart Fail, vol.15, pp.1401-1412, 2013.

G. Ba, . Mm, G. A. Mansoor, J. R. Teerlink, B. M. Massie et al., The predictive value of short-term changes in hemoglobin concentration in patients presenting with acute decompensated heart failure, J Am Coll Cardiol, vol.61, pp.1973-81, 2013.

P. Pellicori, P. Shah, J. Cuthbert, A. Urbinati, J. Zhang et al., Prevalence, pattern and clinical relevance of ultrasound indices of congestion in outpatients with heart failure, Eur J Heart Fail, vol.21, pp.904-916, 2019.

V. Melenovsky, M. J. Andersen, K. Andress, Y. N. Reddy, and B. A. Borlaug, Lung congestion in chronic heart failure: haemodynamic, clinical, and prognostic implications, Eur J Heart Fail, vol.17, pp.1161-71, 2015.

L. B. Daniels and A. S. Maisel, Natriuretic peptides, J Am Coll Cardiol, vol.50, pp.2357-68, 2007.

D. Montero, C. Lundby, F. Ruschitzka, and A. J. Flammer, True Anemia-Red Blood Cell Volume Deficit-in Heart Failure: A Systematic Review, Circ Heart Fail, vol.10, 2017.

P. R. Kalra, C. Anagnostopoulos, A. P. Bolger, A. Coats, and S. D. Anker, The regulation and measurement of plasma volume in heart failure, Journal of the American College of Cardiology, vol.39, pp.1901-1908, 2002.

F. Zannad and P. Rossignol, Cardiorenal Syndrome Revisited. Circulation, vol.138, pp.929-973, 2018.

P. Rossignol, J. Menard, R. Fay, F. Gustafsson, B. Pitt et al., Eplerenone survival benefits in heart failure patients post-myocardial infarction are independent from its diuretic and potassium-sparing effects. Insights from an EPHESUS (Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study) substudy, J Am Coll Cardiol, vol.58, pp.1958-66, 2011.